Literature DB >> 9232273

A point mutation in the human estrogen receptor gene is associated with the expression of an abnormal estrogen receptor mRNA containing a 69 novel nucleotide insertion.

M Wang1, H Dotzlaw, S A Fuqua, L C Murphy.   

Abstract

A novel ER-like mRNA containing a 69 nucleotide insertion precisely between exon 5 and 6 sequences was previously identified in human breast cancer biopsy samples. Data are presented which suggest that the 69 nucleotide sequence is normally present in intron 5 of the human estrogen receptor gene. The region corresponding to and surrounding this 69 nucleotide sequence was cloned and the nucleotide sequence determined. Cloning and sequencing of the corresponding region in genomic DNA isolated from a breast tumor expressing the 69 nucleotide inserted ER mRNA, revealed an A-->G point mutation immediately 3' to the 69 nucleotide sequence. This point mutation resulted in the generation of a consensus splice donor site. A consensus splice acceptor site sequence is normally present immediately 5' to the 69 nucleotide sequence. These data are consistent with the 69 nucleotide sequence being recognized as an exon by the splicing machinery, and resulting in processing of a mature ER mRNA containing the 69 nucleotide insert.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9232273     DOI: 10.1023/a:1005753117205

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  10 in total

1.  Pseudoexon activation as a novel mechanism for disease resulting in atypical growth-hormone insensitivity.

Authors:  L A Metherell; S A Akker; P B Munroe; S J Rose; M Caulfield; M O Savage; S L Chew; A J Clark
Journal:  Am J Hum Genet       Date:  2001-07-20       Impact factor: 11.025

2.  Use of antisense oligonucleotides to correct the splicing error in ISCU myopathy patient cell lines.

Authors:  Gregory P Holmes-Hampton; Daniel R Crooks; Ronald G Haller; Shuling Guo; Susan M Freier; Brett P Monia; Tracey A Rouault
Journal:  Hum Mol Genet       Date:  2016-12-01       Impact factor: 6.150

3.  A novel cryptic exon identified in the 3' region of intron 2 of the human dystrophin gene.

Authors:  Van Khanh Tran; Zhujun Zhang; Mariko Yagi; Atsushi Nishiyama; Yasuaki Habara; Yasuhiro Takeshima; Masafumi Matsuo
Journal:  J Hum Genet       Date:  2005-08-30       Impact factor: 3.172

4.  Trichomonas vaginalis adherence mediates differential gene expression in human vaginal epithelial cells.

Authors:  Ashwini Kucknoor; Vasanthakrishna Mundodi; John F Alderete
Journal:  Cell Microbiol       Date:  2005-06       Impact factor: 3.715

5.  Estrogen receptors similarly mediate the effects of 17β-estradiol on cellular responses but differ in their potencies.

Authors:  Yanfang Huang; Xiaodong Li; Mesut Muyan
Journal:  Endocrine       Date:  2010-11-11       Impact factor: 3.633

Review 6.  Alternative splicing and disease.

Authors:  Jamal Tazi; Nadia Bakkour; Stefan Stamm
Journal:  Biochim Biophys Acta       Date:  2008-10-17

7.  Characterization of a disease-associated mutation affecting a putative splicing regulatory element in intron 6b of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Authors:  Valeria Faà; Federica Incani; Alessandra Meloni; Denise Corda; Maddalena Masala; A Maria Baffico; Manuela Seia; Antonio Cao; M Cristina Rosatelli
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

Review 8.  Defective splicing, disease and therapy: searching for master checkpoints in exon definition.

Authors:  Emanuele Buratti; Marco Baralle; Francisco E Baralle
Journal:  Nucleic Acids Res       Date:  2006-07-19       Impact factor: 16.971

9.  Functional studies on the ATM intronic splicing processing element.

Authors:  Marzena A Lewandowska; Cristiana Stuani; Alireza Parvizpur; Francisco E Baralle; Franco Pagani
Journal:  Nucleic Acids Res       Date:  2005-07-19       Impact factor: 16.971

Review 10.  Role of pseudoexons and pseudointrons in human cancer.

Authors:  Maurizio Romano; Emanuele Buratti; Diana Baralle
Journal:  Int J Cell Biol       Date:  2013-09-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.